Publications
Select Publications
- Buckley K.H., Niccum B.A., Maxwell K.N., Katona B.W. Gastric Cancer Risk and Pathogenesis in BRCA1 and BRCA2 Carriers, Cancers, 2022, 14(23), 5953. Cancers Article
- Coughlin S.E., Heald B., Clark D.F., Nielsen S.M., Hatchell K.E., Esplin E.D., Katona B.W. Multigene panel testing yields high rates of clinically actionable variants amongst colorectal cancer patients, JCO Precision Oncology, 2022. JCO PO Article
- Long J.M., Ebrahimzadeh J., Stanich P.P., Katona B.W. Endoscopic surveillance in patients with the highest risk of gastric cancer: Challenges and solutions. Cancer Management and Research, 2022, 14, 2953-2969. Cancer Management and Research Article
- Fernandes C.J., Leung G., Eads J., Katona B.W. Current approaches to the diagnosis and management of gastroenteropancreatic neuroendocrine tumors, Gastroenterology Clinics of North America, 2022, 51(3), 625-647. GI Clinics of NA Article
- Dbouk M., Katona B.W., Brand R.E., Chak A., Syngal S., Farrell J.J., Kastrinos F., Stoffel E.M., Blackford A.L., Rustgi A.K., Dudley B., Lee L.S., Chhoda A., Kwon R., Ginsberg G.G., Klein A.P., Kamel I., Hruban R.H., He J., Shin E.J., Lennon A.M., Canto M.I., Goggins M. The Multicenter Cancer of Pancreas Screening (CAPS) Study: Impact on Stage and Survival, Journal of Clinical Oncology, 2022, 40(28), 3257-3266. JCO Article
- Feng Z., He X., Zhang X., Wu Y., Xing B., Knowles A., Shan Q., Miller S., Hojnacki T., Ma J., Katona B.W., Gade T.P., Schrader J., Metz D.C., June C.H., Hua X. Potent Suppression of Neuroendocrine Tumors and Gastrointestinal Cancers by CDH17CAR T Cells Without Toxicity to Normal Tissues, Nature Cancer, 2022, 3, 581-594. Nature Cancer Article
- Dmitrieva-Posocco O., Wong A.C., Lundgren P., Golos A.M., Descamps H.C., Dohnalová L., Cramer Z., Tian Y., Yueh B., Eskiocak O., Egervari G., Lan Y., Liu J., Fan J., Kim J., Madhu B., Schneider K.M., Khoziainova S., Andreeva N., Wang Q., Li N., Furth E.E., Bailis W., Kelsen J.R., Hamilton K.E., Kaestner K.H., Berger S.L., Epstein J.A., Jain R., Li M., Beyaz S., Lengner C.J., Katona B.W., Grivennikov S.I., Thaiss C.A., Levy M. Beta-hydroxybutyrate suppresses colorectal cancer, Nature, 2022, 605(7908), 160-165. Nature Article
- Kumar S., Farha N., Burke C.A., Katona B.W. Upper gastrointestinal cancer surveillance in Lynch syndrome, Cancers, 2022, 14:4. Cancers Article
- Long J.M., Powers J.M., Katona B.W. Evaluation of classic, attenuated, and oligopolyposis of the colon. Gastroenterology Clinics of North America, 2022, 32(1), 95-112. GI Endoscopy Clinics of North America Article
- DeJesse J., Vajravelu R.K., Dudzik C., Constantino G., Long J.M., Wangensteen K.J., Valverde K.D., Katona B.W. Uptake and outcomes of small intestinal and urinary tract cancer surveillance in Lynch syndrome. World Journal of Clinical Oncology, 2021, 12(11), 1023-1036. World Journal of Clinical Oncology Article
-
Katona B.W., Long J.M., Ahmad N.A., Attalla S., Bradbury A.R., Carpenter E.L., Clark D.F., Constantino G., Das K.K., Domchek S.M., Dudzik C., Ebrahimzadeh J., Ginsberg G.G., Heiman J., Kochman M.L., Maxwell K.N., McKenna D.B., Powers J., Shah P.D., Wangensteen K., Rustgi A.K. EUS-based pancreatic cancer surveillance in BRCA1/BRCA2/PALB2/ATM carriers without a family history of pancreatic cancer, Cancer Prevention Research, 2021, 14(11), 1033-1040. Cancer Prevention Research Article
- Katona B.W., Mahmud N., Dbouk M., Ahmad N., Chhoda A., Dudley B., Hayat U., Kwon R.S., Lee L.S., Rustgi A.K., Ukaegbu C., Vasquez L., Volk S., Brand R.E., Canto M.I., Chak A., Farrell J.J., Kastrinos F., Stoffel E.M., Syngal S., Goggins M. COVID-19 related pancreatic cancer surveillance disruptions amongst high-risk individuals, Pancreatology, 2021, 21(6), 1048-1051.
Pancreatology Article - McKenna D.B., Dudzik C., Kumar S., Mahmud N., Katona B.W. COVID-19 disruptions to endoscopic surveillance in Lynch syndrome, Cancer Prevention Research, 2021, 14(5), 521-526.
Cancer Prevention Research Article - Kipnis S.T., Hung M., Kumar S., Heckert J.M., Lee H., Bennet B., Soulen M.C., Pryma D.A., Mankoff D.A., Metz D.C., Eads J.R., Katona B.W. Laboratory, Clinical, and Survival Outcomes Associated With Peptide Receptor Radionuclide Therapy in Patients With Gastroenteropancreatic Neuroendocrine Tumors, JAMA Network Open, 2021, 4(3), e212274.
JAMA Network Open Article - Long J.M., Powers J.M., Stanich P.P., Katona B.W. Clinical management of oligopolyposis of unknown etiology. Current Treatment Options in Gastroenterology, 2021.
Current Treatment Options in Gastroenterology Article - MacFarland S.P., Ebrahimzadeh J.E., Zelley K., Begum L., Bass L.M., Brand R.E., Dudley B., Fishman D.S., Ganzak A., Karloski E., Latham A., Llor X., Plon S., Riordan M., Scollon S., Stadler Z.K., Syngal S., Ukaegbu C., Weiss J., Yurgelun M.B., Brodeur G.M., Mamula P., Katona B.W. Phenotypic differences in Juvenile Polyposis Syndrome with or without a disease-causing SMAD4/BMPR1A variant, Cancer Prevention Research, 2021, 14, 215-222.
Cancer Prevention Research Article - Katona B.W., Hojnacki T., Glynn R.A., Paulosky K.E., Szigety K.M., Cao Y., Zhang X., Feng Z., He X., Ma J., Hua X. Menin-mediated repression of glycolysis in combination with autophagy protects colon cancer against small molecule EGFR inhibitors, Molecular Cancer Therapeutics, 2020, 19, 2319-2329.
Molecular Cancer Therapeutics Article - Katona B.W., Powers J., McKenna D.B., Long J.M., Le A.N., Hausler R., Zelley K., Jennings S., Domchek S.M., Nathanson K.L., MacFarland S.P., Maxwell K.N. Upper gastrointestinal cancer risk and surveillance outcomes in Li-Fraumeni syndrome, American Journal of Gastroenterology, 2020, 115(12), 2095-2097.
American Journal of Gastroenterology Article - Kumar S., Dudzik C.M., Reed M., Long J.M., Wangensteen K.J., Katona B.W. Upper endoscopic surveillance in Lynch syndrome detects gastric and duodenal adenocarcinomas, Cancer Prevention Research, 2020, 13(12), 1047-1054.
Cancer Prevention Research Article - Ebrahimzadeh J.E., Long J.M., Wang L., Nathanson J.T., Siddique S.M., Rustgi A.K., Goldberg D.S., Katona B.W. Associations of sociodemographic and clinical factors with gastrointestinal cancer risk assessment appointment completion. Journal of Genetic Counseling, 2020, 29(4), 616-624.
Journal of Genetic Counseling Article - Heckert J.M., Kipnis S.T., Kumar S., Botterbusch S., Alderson A., Bennet B., Creamer C., Eads J.R., Soulen M.C., Pryma D.A., Mankoff D.A., Metz D.C., Katona B.W. Abnormal pre-treatment liver function tests are associated with discontinuation of PRRT in a U.S.-based neuroendocrine tumor cohort. The Oncologist, 2020, 25(7), 572-578.
The Oncologist Article - Clark D.F., Michalski S.T., Tondon R., Nehoray B., Ebrahimzadeh J., Hughes S.K., Soper E.R., Domchek S.M., Rustgi A.K., Pineda-Alvarez D., Anderson M.J., Katona B.W. Loss-of-function variants in CTNNA1 detected on multigene panel testing in individuals with gastric or breast cancer. Genetics in Medicine, 2020, 22(5), 840-846.
Genetics in Medicine Article - Katona B.W., Clark D.F., Domchek S.M. CDH1 on multigene panel testing: Look before you leap. Journal of the National Cancer Institute, 2020, 112(4), 330-334.
Journal of the National Cancer Institute Article - Katona B.W. and Weiss J.M. Chemoprevention of colorectal cancer. Gastroenterology, 2020, 158(2), 368-388.
Gastroenterology Article - Kumar S., Long J.M., Ginsberg G.G., Katona B.W. The role of endoscopy in the management of hereditary diffuse gastric cancer syndrome, World Journal of Gastroenterology, 2019, 25(23), 2878-2886.
World Journal of Gastroenterology Article - Katona B.W., Glynn R.A., Paulosky K.E., Feng Z., Davis C.I., Ma J., Berry C.T., Szigety K.M., Matkar S., Liu Y., Wang H., Wu Y., He X., Freedman B.D., Brady D.C., Hua X. Combined menin and EGFR inhibitors synergize to suppress colorectal cancer via EGFR-independent and calcium-mediated repression of SKP2 transcription, Cancer Research, 2019, 79(9), 2195-2207.
Cancer Research Article - MacFarland S.P., Zelley K., Long J.M., McKenna D., Mamula P., Domchek S.M., Nathanson K.L., Brodeur G.M., Rustgi A.K., Katona B.W., Maxwell K.N. Earlier colorectal cancer screening may be necessary in patients with Li-Fraumeni Syndrome, Gastroenterology, 2019, 156(1), 273-274.
Gastroenterology Article - McKenna D.B., Akker J.V.D., Zhou A.Y., Ryan L., Leon A., O'Connor R., Shah P.D., Rustgi A.K., Katona B.W. Identification of a novel GREM1 duplication in a patient with multiple colon polyps, Familial Cancer, 2019, 18(1), 63-66.
Familial Cancer Article - Katona, B.W., Yurgelun, M.B., Garber, J.E., Offit, K., Domchek, S.M., Robson, M.E., Stadler, Z.K. A counseling framework for moderate-penetrance colorectal cancer susceptibility genes, Genetics in Medicine, 2018, 20(11), 1324-1327.
Genetics in Medicine Article - Katona B.W. and Rustgi A.K. Gastric Cancer Genomics: Advances and Future Directions. Cell Mol. Gastroenterol. Hepatol., 2017, 3(2), 211-217.
Gastric Cancer Genomics Article - Katona B.W., Liu Y., Ma A., Jin J., Hua X. EZH2 inhibition enhances the efficacy of an EGFR inhibitor in suppressing colon cancer cells. Cancer Biol. Ther., 2014, 15(12), 1677-1687.
Cancer Biology & Therapy Article